综合多组学分析与机器学习技术揭示,OGDHL通过谷氨酰胺代谢及组蛋白乙酰化作用,既是胶质母细胞瘤恶性进展的关键调控因子,也是抗肿瘤免疫反应的重要介导因子。
Integrated multi-omics and machine learning identify OGDHL as a key regulator of glioblastoma progression and antitumor immunity via glutamine metabolism and histone lactylation
Xindong Shi, Xiao Hu, Ziyan Shi, Fang Chen
Journal:INTERNATIONAL JOURNAL OF NEUROSCIENCE
IF:1.7
DOI:10.1080/00207454.2026.2705220
PMID:42458724
Published:2026-07-15
research field:分子生物学免疫学炎症传染病学呼吸医学病毒学细胞死亡
Abstract
Background Glioblastoma (GBM) has an extremely poor prognosis, and its malignant progression is closely associated with glutamine metabolic reprogramming and immune evasion; however, the key regulatory networks remain unclear.Methods This study integrated bioinformatics data and identified key proteins through weighted gene co-expression network analysis (WGCNA), screening for differentially expressed proteins (DEPs), and machine learning algorithms. The functions and molecular mechanisms were validated using in vitro cell experiments and in vivo mouse models.Results Oxoglutarate dehydrogenase L (OGDHL) was identified as the key protein in GBM it was down-regulated in both GBM and low-grade glioma (LGG) tissues and was correlated with immune cell infiltration. OGDHL overexpression inhibited GBM cell proliferation and reduced glutamate, α-ketoglutarate (α-KG), and lactate production and programmed death-ligand 1 (PD-L1) expression, while promoting apoptosis. OGDHL overexpression enhanced CD8+ T cell-mediated cytotoxicity and interferon-γ (IFN-γ) secretion. Mechanistically, OGDHL overexpression suppressed histone H3 lysine 18 lactylation (H3K18la) enrichment, reduced luciferase activity, and inhibited PD-L1 expression in GBM cells, effects that were rescued by exogenous lactate supplementation. In vivo, OGDHL up-regulation inhibited tumor growth, reduced glutamate and lactate production, and decreased Ki-67- and PD-L1-positive cells, while increasing OGDHL-positive cells.Conclusion OGDHL exerts a tumor-suppressive function in GBM by regulating glutamine metabolism and histone lactylation-mediated PD-L1 expression, representing a potential new target for immunometabolic therapy.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


